Canopy Growth Corp (CGC)
$24.58 0.46 (1.89%)
11:53 EST CGC Stock Quote Delayed 15 Minutes
Previous Close $24.12
Market Cap 5.31B
PE Ratio -
Volume (Avg. Vol.) 3.56M
Day's Range 23.74 - 25.00
52-Week Range 13.81 - 52.74
Dividend & Yield N/A (N/A)
CGC Stock Predictions, Articles, and Canopy Growth Corp News
- From InvestorPlace
- From the Web
Canopy’s ramped up spending to get its Cannabis 2.0 products into the hands of consumers, along with launching its first hemp-derived CBD product in the U.S., are two things InvestorPlace’s Mark Hake believes will continue to hurt the company’s margins.
Calendar 2019 was the year that CGC stock lost its "mojo", and 2020 will be the year that the stock gets it back.
Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
Canopy Growth has been hammered in 2019, along with the the rest of the cannabis space. Is a rebound ready to go?
Canopy Growth stock outlook darkens with more losses. Canopy Growth reported lower revenue and further losses for its September quarter with profitability nowhere on the horizon.
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
The cannabis industry suffered horribly in 2019 and Aurora Cannabis’ controversial executive departure creates a trust issue for Canopy Growth and other major players.
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
By Thomas Niel
With strong capitalization, Canopy Growth is a "safer" pot stock play. But to tilt the odds in your favor, take your time before buying.
Despite the fact that APHA has posted two straight profitable quarters, Aphria stock has been hit hard this week as Cannabis 2.0 stumbles.
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.
One of the negative headlines that riveted the nation was the vaping crisis. However, a deeper look into the details suggests that contrarians have upside opportunities with vaping stocks to buy.
Investors who are looking for marijuana stocks should have CGC on their radar as it looks like the best of the bunch right now.
Even with its recent run-up, Canopy Growth stock is still down more than 20% for the year. Can Klein turn things around?
There's no question 2019 has been a brutal year for CGC stock investors. However, nothing has changed about Canopy's long-term bullish thesis, and there are several potential catalysts ahead in 2020.
There are profits in trading Canopy Growth stock as the sector finds its footing on Wall Street. CGC is in a rebound effort from earnings.
Navellier RatingsPowered by Portfolio Grader